معرفی
Dr Paul Flynn serves as an Affiliated Assistant Professor at the School of Clinical Medicine, University of Cambridge, and Consultant Physician in Acute and Metabolic Medicine at Addenbrooke's Hospital. He previously held Clinical Director roles for Acute Medicine and Cardiovascular-Metabolic Medicine, and currently chairs the hospital's Clinical Ethics Advisory Group.
His educational foundation includes Pre-clinical and Clinical Medicine studies at the University of Cambridge, followed by a PhD investigating the vascular pathogenicity of Lipoprotein(a).
Research Interests:
- Lipoprotein Metabolism
- Cardiovascular Risk Reduction
- Adult Metabolic Medicine
- Cholesterol Metabolism
- Cardiovascular Disease Prevention
Dr Flynn's work focuses on the molecular mechanisms of lipoprotein metabolism—particularly Lipoprotein(a)—and translating lipid management strategies into clinical interventions for cardiovascular risk reduction. His clinical practice in Metabolic Medicine directly informs his research on therapeutic approaches to prevent cardiovascular events through targeted lipid treatment.
He maintains active hospital leadership through ethics governance and has contributed to clinical service development during his tenure as Clinical Director across multiple departments.
